Literature DB >> 7880128

Antiperinuclear factor in the polyarticular form of juvenile chronic arthritis: are use of frozen material or age of patients relevant?

J M Berthelot.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7880128      PMCID： PMC1005519          DOI： 10.1136/ard.54.1.76-b

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  4 in total

1.  Antiperinuclear factor in juvenile rheumatoid arthritis.

Authors:  G Nesher; T L Moore; M W Grisanti; E el-Najdawi; T G Osborn
Journal:  Ann Rheum Dis       Date:  1992-03       Impact factor: 19.103

2.  Antiperinuclear and anti-RA33 antibodies in juvenile chronic arthritis.

Authors:  G Nesher; V K Wilson; T L Moore; T G Osborn; V E Hanna
Journal:  Ann Rheum Dis       Date:  1994-04       Impact factor: 19.103

Review 3.  The antiperinuclear factor. I. Clinical and serologic associations.

Authors:  P Youinou; P Le Goff; A Dumay; A Lelong; P Fauquert; J Jouquan
Journal:  Clin Exp Rheumatol       Date:  1990 May-Jun       Impact factor: 4.473

4.  Occurrence of antiperinuclear, antikeratin, and anti-RA 33 antibodies in juvenile chronic arthritis.

Authors:  C Gabay; A M Prieur; O Meyer
Journal:  Ann Rheum Dis       Date:  1993-11       Impact factor: 19.103
  4 in total
  1 in total

1.  Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.

Authors:  T Avcin; R Cimaz; F Falcini; F Zulian; G Martini; G Simonini; V Porenta-Besic; G Cecchini; M O Borghi; P L Meroni
Journal:  Ann Rheum Dis       Date:  2002-07       Impact factor: 19.103
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.